U.S. Momentum Factor Vanguard ETF (VFMO)

$177.52 -0.87 (-0.49%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 43,016
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund invests primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by investing in stocks with strong recent performance as determined by the advisor. The portfolio will include a diverse mix of companies representing many different market sectors and industry groups. Under normal circumstances, at least 80% of the fund's assets will be invested in securities issued by U.S. companies.

Phone: 6106696295
StocktwitsNews
StocktwitsNews Sep. 30 at 4:44 PM
AnaptysBio Stock Gets A Price Target Hike After Announcing Plan To Separate Royalty, Biopharma Businesses – Check Out The New Level $ANAB $VFMO $UWM https://stocktwits.com/news/equity/markets/anaptysbio-stock-gets-price-target-hike-after-announcing-plan-to-separate-royalty-biopharma-business/chDDWF9R39Q
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 25 at 10:54 AM
Eli Lilly Terminates Study Of Bimagrumab In Obesity $LLY $JGRO $VFMO https://stocktwits.com/news/equity/markets/eli-lilly-terminates-study-of-bimagrumab-in-obesity/chDlEmYR34I
1 · Reply
StocktwitsNews
StocktwitsNews Sep. 23 at 5:15 PM
Eli Lilly Announces Plan To Construct New $6.5B Facility In Texas $LLY $JGRO $VFMO https://stocktwits.com/news/equity/markets/eli-lilly-announces-plan-to-construct-new-6.5-billion-facility-in-texas/chDLT1fR35C
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 23 at 2:08 PM
Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues $SRRK $VFMO $EAOR https://stocktwits.com/news/equity/markets/scholar-rock-in-spotlight-after-fda-refuses-to-approve-muscular-atrophy-treatment/chDhUSIR35Z
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 19 at 5:01 PM
KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year $KALV $VFMO $VTWG https://stocktwits.com/news/equity/markets/kalvista-pharmaceuticals-hereditary-angioedema-drug-approved-in-eu-switzerland/chD3BkIR3TW
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 18 at 2:36 PM
Uber Inks Partnership With Flytrex For Drone Delivery In US: Retail Sees Stock ‘Going Higher For Longer’ $UBER $JGRO $VFMO https://stocktwits.com/news/equity/markets/uber-inks-partnership-with-flytrex-for-drone-delivery-in-us/chDczS2R3bX
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 17 at 6:36 PM
Roivant Stock Rises After Drug Achieves Goals In Late-Stage Study: Retail Sees Further Rally To $17 $ROIV $VFMO $PKW https://stocktwits.com/news/equity/markets/roivant-drug-achieves-goals-in-late-stage-study/chDGUrPRd6v
1 · Reply
StocktwitsNews
StocktwitsNews Sep. 17 at 3:00 PM
Duolingo Stock Dips After Citigroup Lowers Price Target – Here’s What The Analyst Said About Duocon Event $DUOL $VFMO $AVUS $EAOR https://stocktwits.com/news/equity/markets/duolingo-stock-dips-after-citigroup-lowers-price-target/chDGtG6Rd6k
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 16 at 2:53 PM
Eli Lilly To Set Up $5B Facility In Virginia – More Details Inside $LLY $JGRO $VFMO https://stocktwits.com/news/equity/markets/eli-lilly-to-set-up-5-billion-facility-in-virginia/chwymFcRdzj
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 16 at 2:33 PM
Ralph Lauren Unveils Three-Year Outlook – Here Are The Key Points $RL $VFMF $VFMO $SPXV https://stocktwits.com/news/equity/markets/ralph-lauren-unveils-three-year-outlook/chwym5jRdz0
0 · Reply
Latest News on VFMO
VFMO: Sticking With The Vanguard Momentum Strategy Amid Sector Rotation

Mar 28, 2025, 7:30 AM EDT - 6 months ago

VFMO: Sticking With The Vanguard Momentum Strategy Amid Sector Rotation

VFMO: Diversification A Negative For Vanguard's Momentum ETF

Jan 14, 2025, 3:39 AM EST - 9 months ago

VFMO: Diversification A Negative For Vanguard's Momentum ETF

VFMO: Strong Diversification, Solid Returns With This Momentum ETF

Oct 25, 2024, 11:19 PM EDT - 1 year ago

VFMO: Strong Diversification, Solid Returns With This Momentum ETF

VFMO: A Diversified Momentum ETF At Modest Valuation

Jul 18, 2024, 9:51 AM EDT - 1 year ago

VFMO: A Diversified Momentum ETF At Modest Valuation

VFMO: Inexpensive ETF Outperforming The S&P 500 And Peer Funds

Apr 30, 2024, 11:01 PM EDT - 1 year ago

VFMO: Inexpensive ETF Outperforming The S&P 500 And Peer Funds

Vanguard Has 17 Small And Mid-Cap ETFs. Which Are Best Right Now?

Mar 8, 2024, 2:55 AM EST - 1 year ago

Vanguard Has 17 Small And Mid-Cap ETFs. Which Are Best Right Now?

IVOG IVOO IVOV VBK VBR VFMF VFQY

You'd Be Surprised Which Four Vanguard ETFs Have Consistently Beaten Their Category Averages

Feb 18, 2024, 1:14 AM EST - 1 year ago

You'd Be Surprised Which Four Vanguard ETFs Have Consistently Beaten Their Category Averages

VFMF VFMV VFQY VFVA VO VOE VOO

VFMO: Assessing Momentum As A Strategy Versus SPY Near All-Time Highs

Feb 15, 2024, 4:48 AM EST - 1 year ago

VFMO: Assessing Momentum As A Strategy Versus SPY Near All-Time Highs

VFMO: Only One Tool In The Toolbox

Jun 14, 2023, 5:20 AM EDT - 2 years ago

VFMO: Only One Tool In The Toolbox

VFMO Vs. MTUM: Little Followed Momentum ETF Beating Better Known One

Jan 19, 2023, 9:30 AM EST - 2 years ago

VFMO Vs. MTUM: Little Followed Momentum ETF Beating Better Known One

MTUM

Franklin Custodian Funds' Dynatech Fund: Don't Buy This Dip – Legacy Fund Ratings Are Misleading

Apr 4, 2022, 9:16 AM EDT - 3 years ago

Franklin Custodian Funds' Dynatech Fund: Don't Buy This Dip – Legacy Fund Ratings Are Misleading

FFTY

QMOM ETF Ranked Best Among US Momentum Smart Beta ETFs

Aug 3, 2021, 12:29 PM EDT - 4 years ago

QMOM ETF Ranked Best Among US Momentum Smart Beta ETFs

QMOM

Why Vanguard Should Retire The U.S. Momentum Factor ETF

Feb 17, 2020, 9:18 AM EST - 6 years ago

Why Vanguard Should Retire The U.S. Momentum Factor ETF

StocktwitsNews
StocktwitsNews Sep. 30 at 4:44 PM
AnaptysBio Stock Gets A Price Target Hike After Announcing Plan To Separate Royalty, Biopharma Businesses – Check Out The New Level $ANAB $VFMO $UWM https://stocktwits.com/news/equity/markets/anaptysbio-stock-gets-price-target-hike-after-announcing-plan-to-separate-royalty-biopharma-business/chDDWF9R39Q
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 25 at 10:54 AM
Eli Lilly Terminates Study Of Bimagrumab In Obesity $LLY $JGRO $VFMO https://stocktwits.com/news/equity/markets/eli-lilly-terminates-study-of-bimagrumab-in-obesity/chDlEmYR34I
1 · Reply
StocktwitsNews
StocktwitsNews Sep. 23 at 5:15 PM
Eli Lilly Announces Plan To Construct New $6.5B Facility In Texas $LLY $JGRO $VFMO https://stocktwits.com/news/equity/markets/eli-lilly-announces-plan-to-construct-new-6.5-billion-facility-in-texas/chDLT1fR35C
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 23 at 2:08 PM
Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues $SRRK $VFMO $EAOR https://stocktwits.com/news/equity/markets/scholar-rock-in-spotlight-after-fda-refuses-to-approve-muscular-atrophy-treatment/chDhUSIR35Z
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 19 at 5:01 PM
KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year $KALV $VFMO $VTWG https://stocktwits.com/news/equity/markets/kalvista-pharmaceuticals-hereditary-angioedema-drug-approved-in-eu-switzerland/chD3BkIR3TW
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 18 at 2:36 PM
Uber Inks Partnership With Flytrex For Drone Delivery In US: Retail Sees Stock ‘Going Higher For Longer’ $UBER $JGRO $VFMO https://stocktwits.com/news/equity/markets/uber-inks-partnership-with-flytrex-for-drone-delivery-in-us/chDczS2R3bX
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 17 at 6:36 PM
Roivant Stock Rises After Drug Achieves Goals In Late-Stage Study: Retail Sees Further Rally To $17 $ROIV $VFMO $PKW https://stocktwits.com/news/equity/markets/roivant-drug-achieves-goals-in-late-stage-study/chDGUrPRd6v
1 · Reply
StocktwitsNews
StocktwitsNews Sep. 17 at 3:00 PM
Duolingo Stock Dips After Citigroup Lowers Price Target – Here’s What The Analyst Said About Duocon Event $DUOL $VFMO $AVUS $EAOR https://stocktwits.com/news/equity/markets/duolingo-stock-dips-after-citigroup-lowers-price-target/chDGtG6Rd6k
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 16 at 2:53 PM
Eli Lilly To Set Up $5B Facility In Virginia – More Details Inside $LLY $JGRO $VFMO https://stocktwits.com/news/equity/markets/eli-lilly-to-set-up-5-billion-facility-in-virginia/chwymFcRdzj
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 16 at 2:33 PM
Ralph Lauren Unveils Three-Year Outlook – Here Are The Key Points $RL $VFMF $VFMO $SPXV https://stocktwits.com/news/equity/markets/ralph-lauren-unveils-three-year-outlook/chwym5jRdz0
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 16 at 12:51 PM
Dave & Buster’s Sees Wall Street Downgrades, Yet Retail Sentiment Red-Hot $PLAY $VFMO $PKW $IWMW https://stocktwits.com/news/equity/markets/dave-and-buster-s-sees-wall-street-downgrades-yet-retail-sentiment-red-hot/chwy1WbRdze
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 5 at 5:09 PM
Caleres Draws ‘Less Risk’ Rating From Telsey, Retail Chatter Surges 700% $CAL $VFMF $VFMO https://stocktwits.com/news/equity/markets/caleres-draws-less-risk-rating-from-telsey/chwIjY0Rdq0
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 4 at 5:40 PM
Summit Therapeutics Gets A $40 Price Target As Guggenheim Says It Likes Stock At $24, Like It Did At $3 $SMMT $VFMO $ESGV https://stocktwits.com/news/equity/markets/summit-therapeutics-gets-40-dollar-price-target-from-guggenheim/chwdQXARdpT
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 4 at 3:05 PM
Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More $AGIO $VFMO $IWMW https://stocktwits.com/news/equity/markets/agios-pharma-stock-slumps-but-company-remains-top-pick-for-analyst/chwdJJlRdYs
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 2 at 1:22 PM
Zymeworks Stock Tanks Over 17% After Cancer Drug Candidate Update $ZYME $VFMO $IWMW https://stocktwits.com/news/equity/markets/zymeworks-stock-tanks-after-cancer-drug-candidate-update/chv6sI8Rdny
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 19 at 3:56 PM
Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’ $IOVA $VFMO $IWMW https://stocktwits.com/news/equity/markets/iovance-stock-rises-on-health-canada-approval-for-cancer-immunotherapy/chsgV4qRdW2
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 15 at 2:54 PM
Lyft Has A ‘Steady Path Forward’ According To UBS: Retail Thinks Stock Is Undervalued $LYFT $VFMO $AVUS https://stocktwits.com/news/equity/markets/lyft-has-steady-path-forward-according-to-ubs/chsPszdRdf8
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 13 at 5:45 PM
HC Wainwright Doubles Price Target On Insmed After Brinsupri Approval: Retail Expects Stock To Hit $150 By End Of Week $INSM $JGRO $VFMO https://stocktwits.com/news/equity/markets/hc-wainwright-doubles-price-target-on-insmed-after-brinsupri-approval/chrCj76Rd9u
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 3:42 PM
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming $ARDX $VFMO $IWMW https://stocktwits.com/news/equity/markets/ardelyx-stock-soars-on-price-target-hikes-after-upbeat-q2-report/chrLvsyRd28
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 1:11 PM
Vertex Stock Sinks 12% As Pipeline Setbacks Trigger Wall Street Skepticism: But Retail Sees Opportunity $VRTX $VFMO https://stocktwits.com/news/equity/markets/vertex-pharmaceuticals-pipeline-setbacks-trigger-wall-street-skepticism/chrLrsERd2f
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 22 at 3:37 PM
Oscar Health Now Expects Loss From Operations Of $200M To $300M In 2025: Here’s What Retail Thinks About The Stock Price $OSCR $VFMO $IWMW https://stocktwits.com/news/equity/markets/oscar-health-now-expects-loss-from-operations-of-200-million-to-300-million-in-2025/ch8MNlyR5tg
1 · Reply
ZacksResearch
ZacksResearch Jul. 18 at 1:36 PM
Trump’s tariff twist: bullish for growth ETFs? Wall Street could rally as 10–15% uniform tariffs ease global trade fears heading into August — with targeted upside for names like $RPG, $VFMO, $FNY and $RFG. Find out which ETFs could benefit most 👉 https://www.zacks.com/stock/news/2590975/wall-street-to-gain-ahead-as-trump-eyes-10-or-15-tariffs?cid=sm-stocktwits-2-2590975-teaser-2478&ADID=SYND_STOCKTWITS_TWEET_2_2590975_TEASER_2478
0 · Reply